CAI (Caris Life Sciences) Net Margin %: -0.24% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI Caris Life Sciences Inc CAI
11 GF Score
Price $15.53
! 2 Warning Signs
View Full Analysis

What is Caris Life Sciences Net Margin %?

Caris Life Sciences CAI -0.89% 11 Net Margin % is -0.24% as of Mar. 2026. GuruFocus rates CAI with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 942 Biotechnology companies, Caris Life Sciences ranks better than 74.42% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Caris Life Sciences's Net Income for the three months ended in Mar. 2026 was $-0.5 Mil. Caris Life Sciences's Revenue for the three months ended in Mar. 2026 was $216.2 Mil. Therefore, Caris Life Sciences's net margin for the quarter that ended in Mar. 2026 was -0.24%.

The historical rank and industry rank for Caris Life Sciences's Net Margin % or its related term are showing as below:

CAI' s Net Margin % Range Over the Past 10 Years
Min: -124.12   Med: -89.96   Max: 3.75
Current: 3.75

CAI's Net Margin % is ranked better than
74.42% of 942 companies
in the Biotechnology industry
Industry Median: -89.445 vs CAI: 3.75

Caris Life Sciences  (NAS:CAI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Caris Life Sciences Net Margin % Related Terms

Caris Life Sciences Net Margin % Historical Data

* Premium members only.

The historical data trend for Caris Life Sciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caris Life Sciences Net Margin % Chart

Caris Life Sciences Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Net Margin %
-124.12 -111.53 -68.38 -8.38

Caris Life Sciences Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -84.84 -39.58 11.22 27.98 -0.24

CAI vs DNTH, MANE, TNGX: Net Margin % Comparison

For the Biotechnology subindustry, Caris Life Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caris Life Sciences Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Caris Life Sciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Caris Life Sciences's Net Margin % falls into.


CAI
11GF Score
Caris Life Sciences Inc CAI
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Caris Life Sciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Caris Life Sciences's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-68.088/812.033
=-8.38 %

Caris Life Sciences's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.51/216.174
=-0.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -0.24% mean?
Caris Life Sciences (CAI) has a Net Margin % of -0.24% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Caris Life Sciences and its competitors. According to the industry distribution chart, Caris Life Sciences ranks #241 out of 942 companies in the Biotechnology industry, placing it in the top 25.6%.
Is Caris Life Sciences' Net Margin % too high?
Caris Life Sciences' current Net Margin % is -0.24%. Based on the distribution chart, Caris Life Sciences ranks #241 out of 942 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Caris Life Sciences has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Caris Life Sciences' Net Margin % compare to DNTH and MANE?
According to the Biotechnology industry distribution chart, Caris Life Sciences ranks #241 out of 942 companies for Net Margin %. This puts Caris Life Sciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Caris Life Sciences and its competitors. Caris Life Sciences's current Net Margin % is -0.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caris Life Sciences stock overvalued right now?
Caris Life Sciences (CAI) has a current Net Margin % of -0.24%. The current Net Margin % is -0.24%. Caris Life Sciences' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Caris Life Sciences (CAI), the current Net Margin % is -0.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caris Life Sciences Business Description

Other Exchanges CAI:Mexico49J:Germany
Address 750 W. John Carpenter Freeway, Suite 800, Irving, TX, USA, 75039
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
11GF Score

Get the complete analysis for CAI

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.53
Price